RECENT NEWS

AmplexDiagnostics and Scope Biosciences have collaborated to produce a groundbreaking solution in molecular diagnostics. ‘eazySNP’ combines molecular technologies LAMP and CRISPR to enable the rapid and highly specific detection of genetic variants.

The World Health Organization (WHO) has launched a new five-year strategy for its Hub for Pandemic and Epidemic Intelligence, charting a path towards a world where every country can detect and understand emerging health threats within 24 hours of their appearance by 2030.

PAMEC (Preparing for and mitigating the impacts of environmental change on Diptera-borne disease in the UK) is a new four-year programme funded with £3.75m by UK Research and Innovation (UKRI) as part of a £20m interdisciplinary research fund to tackle epidemic threats.

Researchers from The Pirbright Institute have developed new tools to identify and study a critical group of immune cells in pigs that help generate protective antibodies following vaccination and infection.

Evident has expanded its Pramana digital pathology portfolio with the POD whole-slide imaging (WSI) scanner, a new benchtop system designed to help laboratories produce trusted images.

Medical logistics firm Apian has announced plans to develop a foundation world model for pathology laboratory logistics and automation, collaborating with service provider Synnovis, and incorporating advanced robotics and physical AI.

The next one-day conference hosted by POCT Innovators – Power to Disrupt: Clinical Diagnostics Now, which will take place on Monday 16 November, in Oxford – has unveiled its speaker line up.

Beckman Coulter Diagnostics, part of the Danaher group of companies, has announced the appointment of Catherine ‘Cat’ Jennings as President.

The Medicines and Healthcare products Regulatory Agency (MHRA) has set out ambitious plans to translate cutting-edge scientific and technological innovation into better health outcomes for patients across all four nations of the UK, in its 2030 Strategy document.

Agilent Technologies has entered into a definitive agreement to acquire digital pathology firm Proscia in an all-cash transaction valued at $240 million in cash and up to an additional $30 million based on achieving future performance milestones.

The UK Government is to award funding of £33.2 million to eight vaccine projects targeting deadly diseases, strengthening UK pandemic preparedness and helping protect people worldwide.

A ‘rising fog’ which may cloud the immune system’s ability to detect tumours could be the key to tackling lung cancer development years before diagnosis.

The National Institute for Health and Care Research (NIHR) and the National Health Innovation Centre Singapore (NHIC) are teaming up to fast-track healthcare innovations across the UK and Singapore that address unmet, shared clinical needs.

The UK Health Security Agency (UKHSA) has appointed Dr Gail Carson as its new Chief Medical Advisor, and confirmed the permanent appointment of Professor Robin May as its Chief Scientific Officer.

ALZpath and Quanterix have announced the expansion of their cooperation, which will broaden the use of ALZpath's proprietary pTau217 antibody technology across the Quanterix Simoa research portfolio.

Aiforia, a developer of AI-powered solutions for cancer diagnostics, has won the prestigious ‘Vuoden Digiteko 2026’ (Digital Innovation of the Year) public vote in the enterprise category.

Consultant Clinical Scientist Dr Fiona Riddoch has been appointed as Specialty Lead for Point-of-Care Testing across the Berkshire and Surrey Pathology Services (BSPS) network.

The UK Health Security Agency (UKHSA) has highlighted that influenza levels during September – while still low - were higher than in the previous four years, raising the prospect of an early ‘flu season.

Roche Diagnostics has provided two molecular testing instruments to the Democratic Republic of Congo’s Institut National de Santé Publique (INSP) to support Ebola testing capacity in the country.

AI Pathology firm Aiforia has announced a commercial agreement with PathAI - the developer of the AISight Dx Image Management System - for Aiforia's AI solutions to be made available to laboratories through the AISight Marketplace.